Did Stryker MAKO a Mistake?

Did Stryker Mako Mistake? (OrthoSpineNews) Stryker  (download 4-page analysis of Stryker HERE) plans to pay a pretty penny for robot-assisted surgery outfit MAKO Surgical, signing up to trade $1.7 billion for the company, an 86% premium to its latest closing price. Through the deal, Stryker gets Mako’s Rio system–a robot-assisted surgical device used in orthopedic procedures–and the company’s fleet of Restoris implants. Sales and services for Rio systems led Mako to $102.7 million in revenue last year, a 22% jump over 2011. Stryker, by paying nearly twice Mako’s market cap, clearly has quite a...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top